| Nilima Reddy Mosaly, MD | |
|
2310 Erwin Rd, Durham, NC 27710-8710 | |
| (984) 209-3773 | |
| Not Available |
| Full Name | Nilima Reddy Mosaly |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 23 Years |
| Location | 2310 Erwin Rd, Durham, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417166067 | NPI | - | NPPES |
| 5916517 | Medicaid | NC | |
| FH1101020 | Other | NC | FIRSTCAROLINA CARE |
| 162R1 | Other | NC | BCBS OF NC |
| 8485484 | Other | NC | CIGNA HEALTH CARE |
| P00906695 | Other | NC | RR MEDICARE |
| 9465225 | Other | NC | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 4301086554 (Michigan) | Secondary |
| 208M00000X | Hospitalist | 10-00439 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Duke University Hospital | Durham, NC | Hospital |
| Duke Health Raleigh Hospital | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke University Health System Inc | 2567372345 | 837 |
News Archive
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM200 showed accurate performance compared with invasive point of care devices.
NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.
A two-day WHO and World Bank ministerial-level meeting on universal health coverage (UHC) began in Geneva on Monday, bringing "together ministers of finance and health from 27 countries with other high-level stakeholders" to discuss "exploring ways that countries are progressing towards universal health coverage, sharing innovative solutions and identifying actions the global community can take to support efforts," the Global Dispatch reports.
Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., today announced that it has closed on $175 million of new senior secured credit facilities. Bank of America Merrill Lynch served as administrative agent. Bank of Montreal and SunTrust Bank served as co-syndication agents.
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
› Verified 4 days ago
| Entity Name | Firsthealth Of The Carolinas Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548276389 PECOS PAC ID: 8820909377 Enrollment ID: O20031108000016 |
News Archive
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM200 showed accurate performance compared with invasive point of care devices.
NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.
A two-day WHO and World Bank ministerial-level meeting on universal health coverage (UHC) began in Geneva on Monday, bringing "together ministers of finance and health from 27 countries with other high-level stakeholders" to discuss "exploring ways that countries are progressing towards universal health coverage, sharing innovative solutions and identifying actions the global community can take to support efforts," the Global Dispatch reports.
Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., today announced that it has closed on $175 million of new senior secured credit facilities. Bank of America Merrill Lynch served as administrative agent. Bank of Montreal and SunTrust Bank served as co-syndication agents.
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
› Verified 4 days ago
| Entity Name | Duke University Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376574798 PECOS PAC ID: 2567372345 Enrollment ID: O20031126000274 |
News Archive
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM200 showed accurate performance compared with invasive point of care devices.
NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.
A two-day WHO and World Bank ministerial-level meeting on universal health coverage (UHC) began in Geneva on Monday, bringing "together ministers of finance and health from 27 countries with other high-level stakeholders" to discuss "exploring ways that countries are progressing towards universal health coverage, sharing innovative solutions and identifying actions the global community can take to support efforts," the Global Dispatch reports.
Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., today announced that it has closed on $175 million of new senior secured credit facilities. Bank of America Merrill Lynch served as administrative agent. Bank of Montreal and SunTrust Bank served as co-syndication agents.
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of North Carolina Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164724902 PECOS PAC ID: 0143409185 Enrollment ID: O20110124000754 |
News Archive
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM200 showed accurate performance compared with invasive point of care devices.
NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.
A two-day WHO and World Bank ministerial-level meeting on universal health coverage (UHC) began in Geneva on Monday, bringing "together ministers of finance and health from 27 countries with other high-level stakeholders" to discuss "exploring ways that countries are progressing towards universal health coverage, sharing innovative solutions and identifying actions the global community can take to support efforts," the Global Dispatch reports.
Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., today announced that it has closed on $175 million of new senior secured credit facilities. Bank of America Merrill Lynch served as administrative agent. Bank of Montreal and SunTrust Bank served as co-syndication agents.
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
› Verified 4 days ago
| Entity Name | Fhpg Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336154129 PECOS PAC ID: 9537481569 Enrollment ID: O20141202002644 |
News Archive
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM200 showed accurate performance compared with invasive point of care devices.
NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.
A two-day WHO and World Bank ministerial-level meeting on universal health coverage (UHC) began in Geneva on Monday, bringing "together ministers of finance and health from 27 countries with other high-level stakeholders" to discuss "exploring ways that countries are progressing towards universal health coverage, sharing innovative solutions and identifying actions the global community can take to support efforts," the Global Dispatch reports.
Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., today announced that it has closed on $175 million of new senior secured credit facilities. Bank of America Merrill Lynch served as administrative agent. Bank of Montreal and SunTrust Bank served as co-syndication agents.
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nilima Reddy Mosaly, MD 2310 Erwin Rd, Durham, NC 27704-0001 Ph: (984) 209-3773 | Nilima Reddy Mosaly, MD 2310 Erwin Rd, Durham, NC 27710-8710 Ph: (984) 209-3773 |
News Archive
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM200 showed accurate performance compared with invasive point of care devices.
NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.
A two-day WHO and World Bank ministerial-level meeting on universal health coverage (UHC) began in Geneva on Monday, bringing "together ministers of finance and health from 27 countries with other high-level stakeholders" to discuss "exploring ways that countries are progressing towards universal health coverage, sharing innovative solutions and identifying actions the global community can take to support efforts," the Global Dispatch reports.
Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., today announced that it has closed on $175 million of new senior secured credit facilities. Bank of America Merrill Lynch served as administrative agent. Bank of Montreal and SunTrust Bank served as co-syndication agents.
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
› Verified 4 days ago
Jose Antonio Lozano, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 508 Fulton St, Durham, NC 27705 Phone: 919-286-0411 | |
Meena K Mohan, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 3643 N Roxboro St, Durham, NC 27704 Phone: 919-470-4000 | |
Dr. Philip Chu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2301 Erwin Rd Cb 2918, Durham, NC 27710 Phone: 919-684-8111 | |
Dr. Sandra Beth Brown, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2301 Erwin Road Duke University Medical Center, Durham, NC 27710 Phone: 919-684-2496 Fax: 919-668-5271 | |
Zubair Ur Rehman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2310 Erwin Road, Durham, NC 27710 Phone: 919-954-3000 | |
Ali R. Qamar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 40 Duke Medicine Cir, Durham, NC 27710 Phone: 919-684-8111 | |
Dr. Emily E Ray Ko, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4103 Graceview Way, Durham, NC 27705 Phone: 206-240-3764 |